Entera Bio Ltd.
NASDAQEntera Bio enters May 14 earnings week with an unusual combination: shorts pulling back sharply, the stock up 18% on the week, and a 19.6 million share secondary filing landing the same afternoon as Q1 results. That tension — a technically strengthening tape against a fresh dilution overhang — frames everything worth watching right now. The short side has quietly deflated over the…
ENTX short interest plunges 34% in one week to 0.33% of float, lowest level since April as stock rallies 15%.
Snapshot as of 24 Jun 2026
Entera Bio enters May 14 earnings week with an unusual combination: shorts pulling back sharply, the stock up 18% on the week, and a 19.6 million share secondary filing landing the same afternoon as Q1 results. That…
Short interest updated daily, real-time options flow, analyst consensus deltas, 13F positioning, ORTEX Alpha signals, and every article ORTEX publishes for ENTX — free to start on ORTEX.
Sign up for free →Open ENTX on ORTEXPulses are triggered by ORTEX's live data feeds. The full signal history, thresholds, and alerts are on ORTEX.
Live ENTX data →